Legal Representation
Attorney
Cynthia J. Walden
USPTO Deadlines
Application History
39 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 22, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Aug 22, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Jan 25, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 24, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 20, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 20, 2011 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 1, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 30, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 28, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 28, 2010 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 8, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 5, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 5, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Feb 27, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 27, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 12, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 12, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 20, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 28, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 8, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Sep 19, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
Sep 19, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Sep 11, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 11, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 11, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 11, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 11, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 18, 2008 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Aug 18, 2008 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Aug 18, 2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Aug 11, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 11, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 11, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 23, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 23, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 23, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 22, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 20, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
Mar 19, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Test reagents for medical diagnosis; contrast media for use with X-ray, ultrasound and MRI medical and veterinary imaging; pharmaceutical products, namely, pharmaceutical preparations for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus, vasculitis, cancer, IBD, namely, ulcerative colitis and Crohn's disease, psoriasis, cutaneous lupus erythematosus, dermatitis, pemphigus, multiple sclerosis, demyelinating autoimmune diseases, Guillain-Barre syndrome neuromyelitis optica, myesthenia gravis, opthalmia, asthma, allergic rhinitis, hypersensitivity, anemia, diabetes mellitus, cardiovascular diseases, namely, angina pectoris, hypertension, myocardial infarction, CNS-disorders, namely, depression, schizophrenia, muscular spasm and pain, epilepsy
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of Stylization of "SANOCHEMIA" over "CORPORATION USA", all over heavy black line.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CORPORATION" AND "USA"